Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,016 across all filing types
Latest filing 2025-10-21 Regulatory Filings
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
GSK share positive Ph3 data on tebipenem HBr
Regulatory Filings Classification · 100% confidence The document is a press release issued via the Regulatory News Service (RNS) by GSK PLC. It details the results of a Phase III clinical trial (PIVOT-PO) for a new drug, tebipenem HBr. While it contains scientific and clinical data, it is an announcement of trial results rather than a formal financial report, audit, or regulatory filing. In the context of corporate communications, such announcements regarding clinical trial outcomes are classified as Regulatory Filings (RNS) as they serve as the primary channel for disseminating material company news to the market.
2025-10-21 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-10-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK PLC regarding the purchase of its own shares (share buyback). It includes specific details such as the date of purchase, the number of shares acquired, price information, and a detailed schedule of individual trades. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2025-10-20 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-10-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares as part of a buyback program. It includes specific details such as the number of shares purchased, price paid, trading venues, and the resulting impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-10-17 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2025-10-16 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.